Magenta Therapeutics Completes Dosing in Phase 1 MGTA-145 Trial, Demonstrating Rapid, Single-Day First Line Stem Cell Mobilization and Collection
– Updated data from the Phase 1 study in healthy subjects show that MGTA-145, in combination with plerixafor, met all…